ArticleMolecular cancer therapeutics2018

Scavenger Receptor Type B1 and Lipoprotein Nanoparticle Inhibit Myeloid-Derived Suppressor Cells.

Michael P Plebanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.